Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients 'on behalf of the group of surgeons from the French unicancer federation'

Annals of Oncology

Volumn 23, Issue 5, 2012, Pages 1170-1177

  Classe, J M ^a   Baffert, S ^b   Sigal Zafrani, B ^b   Fall, M ^b   Rousseau, C ^a   Alran, S ^b   Rouanet, P ^c   Belichard, C ^d   Mignotte, H ^e   Ferron, G ^f   Marchal, F ^g   Giard, S ^h   Tunon de Lara, C ⁱ   Le Bouedec, G ^j   Cuisenier, J ^k   Werner, R ^l   Raoust, I ^m   Rodier, J F ⁿ   Laki, F ^b   Colombo, P E ^c   Lasry, S ^d   Faure, C ^e   Charitansky, H ^f   Olivier, J B ^g   Chauvet, M P ^h   Bussieres E ⁱ   Gimbergues, P ^j   Flipo, B ^m   Houvenaeghel, G ^o   Dravet, F ^a   Livartowski, A ^b   more..

^a Institut de Cancérologie de l'Ouest Gauducheau   (France)

^b INSTITUT CURIE   (France)

^c Center Val d'Aurel Montpellier   (France)

^d Center René Huguenin   (France)

^e CENTRE LÉON BÉRARD   (France)

^f INSTITUT CLAUDIUS REGAUD   (France)

^g CENTRE ALEXIS VAUTRIN   (France)

^h Center Oscar Lambret   (France)

ⁱ Bergonié Anti cancer Institute   (France)

^j Surgical Department   (France)

^k CENTRE GEORGES FRANÇOIS LECLERC   (France)

^l INSTITUT JEAN GODINOT   (France)

^m Lacassagne Center   (France)

ⁿ Paul Strauss Centre   (France)

^o INSTITUT PAOLI CALMETTES   (France)

more..

Author keywords

Axillary lymphadenectomy; Breast cancer; Cost; Sentinel lymph node

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCINTISCANNING; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HEALTH CARE COST; HOSPITAL COST; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENTINEL LYMPH NODE;

EID: 84860475798     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr355     Document Type: Article

References (25)

1. Hill C, Doyon F. The frequency of cancer in France in year 2002, and trends since 1968]. Bull Cancer 2006; 93: 7-11.
2. Turner RR, Ollila DW, Krasne DL et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271-276; discussion 276-278.
3. Mansel RE, Fallowfield L, Kissin M et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98: 599-609.
4. Benson JR, della Rovere GQ. Management of the axilla in women with breast cancer. Lancet Oncol 2007; 8: 331-348.
5. Lyman GH, Giuliano AE, Somerfield MR et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-7720.
6. Rodier JF, Velten M, Wilt M et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol 2007; 25: 3664-3669.
7. Krag DN, Weaver DL, Alex JC et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339; discussion 340.
8. Victorzon M, Hamalainen E, Svartback M et al. Extra-axillary sentinel node biopsy in breast cancer staging-is it necessary? Eur J Surg Oncol 2003; 29: 604-606.
9. Dupont EL, Kamath VJ, Ramnath EM et al. The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol 2001; 8: 354-360.
10. McMasters KM, Wong SL, Tuttle TM et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000; 231: 724-731.
11. Goyal A, Newcombe RG, Mansel RE et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer 2005; 41: 238-243.
12. Kaminski JP, Case D, Howard-McNatt M et al. Sentinel lymph node intraoperative imprint cytology in patients with breast cancer-costly or cost effective? Ann Surg Oncol 2010; 17(11): 2920-2925.
13. Cserni G, Amendoeira I, Apostolikas N et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003; 39: 1654-1667.
14. Holm M, Paaschburg B, Balslev E et al. Intraoperative immunohistochemistry staining of sentinel nodes in breast cancer: clinical and economical implications. Breast 2008; 17: 372-375.
15. Canavese G, Bruzzi P, Catturich A et al. Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: always or never? A risk/benefit and cost/benefit analysis. Eur J Surg Oncol 2010; 36: 737-744.
16. Cutress RI, McDowell A, Gabriel FG et al. Observational and cost analysis of the implementation of breast cancer sentinel node intraoperative molecular diagnosis. J Clin Pathol 2010; 63: 522-529.
17. Reed J, Rosman M, Verbanac KM et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg 2009; 208: 333-340.
18. Droeser RA, Frey DM, Oertli D et al. Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis. Breast 2009; 18: 109-114.
19. Roses DF, Brooks AD, Harris MN et al. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 1999; 230: 194-201.
20. Classe JM, Dupre PF, Francois T et al. Axillary padding as an alternative to closed suction drain for ambulatory axillary lymphadenectomy: a prospective cohort of 207 patients with early breast cancer. Arch Surg 2002; 137: 169-172; discussion 173.
21. Bundred N, Maguire P, Reynolds J et al. Randomised controlled trial of effects of early discharge after surgery for breast cancer. BMJ 1998; 317: 1275-1279.
22. Cady B, Stone MD, Schuler JG et al. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996; 131: 301-308.
23. Perrier L, Nessah K, Morelle M et al. Cost comparison of two surgical strategies in the treatment of breast cancer: sentinel lymph node biopsy versus axillary lymph node dissection. Int J Technol Assess Health Care 2004; 20: 449-454.
24. Chirikos TN, Berman CG, Luther SL et al. Cost consequences of sentinel lymph node biopsy in the treatment of breast cancer. A preliminary analysis. Int J Technol Assess Health Care 2001; 17: 626-631.
25. Ronka R, Smitten K, Sintonen H et al. The impact of sentinel node biopsy and axillary staging strategy on hospital costs. Ann Oncol 2004; 15: 88-94.